chrisvoncsefalvay/vaers-outcomes huggingface dataset:
The ticking is like when you are falling asleep and suddenly starts the tickling feeling; Really sore arm; Nausea; Hours after the 2nd dose, the ticking has come back, stronger and sooner than the 1st time ( with the 1st dose) / the ticking is stronger on the opposite side of the vaccine administration , but it is on both hands; This spontaneous case was reported by an other health care professional (subsequently medically confirmed) and describes the occurrence of PARAESTHESIA (Hours after the 2nd dose, the ticking has come back, stronger and sooner than the 1st time ( with the 1st dose) / the ticking is stronger on the opposite side of the vaccine administration , but it is on both hands), SLEEP DISORDER (The ticking is like when you are falling asleep and suddenly starts the tickling feeling), PAIN IN EXTREMITY (Really sore arm) and NAUSEA (Nausea) in a 31-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. does not have the card) for COVID-19 vaccination.     Concomitant products included CALCIUM LEVOMEFOLATE (METHYL FOLATE) and ETHINYLESTRADIOL, NORETHISTERONE ACETATE (MICROGESTIN) for an unknown indication.   On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 11-Mar-2021, the patient experienced PARAESTHESIA (Hours after the 2nd dose, the ticking has come back, stronger and sooner than the 1st time ( with the 1st dose) / the ticking is stronger on the opposite side of the vaccine administration , but it is on both hands), PAIN IN EXTREMITY (Really sore arm) and NAUSEA (Nausea). On an unknown date, the patient experienced SLEEP DISORDER (The ticking is like when you are falling asleep and suddenly starts the tickling feeling). At the time of the report, PARAESTHESIA (Hours after the 2nd dose, the ticking has come back, stronger and sooner than the 1st time ( with the 1st dose) / the ticking is stronger on the opposite side of the vaccine administration , but it is on both hands), SLEEP DISORDER (The ticking is like when you are falling asleep and suddenly starts the tickling feeling), PAIN IN EXTREMITY (Really sore arm) and NAUSEA (Nausea) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment medication reported was acetaminophen (Tylenol) on 11-Mar-2021.   This case was linked to MOD-2021-040678 (Patient Link).
Pfizer-BioNTech COVID-19 Vaccine EUA - Chest Pains radiating to back; headache; shortness of breath; vomiting; sweating; dizziness; faint-like feeling - symptoms began 27 April 2021 and continued to 28 April 2021; went to Emergency Room 28 April 2021 @ 6:30am; diagnosed with Heart attack; Carthirization required; 6 days hospitalization Hospital.
Pt recvd vax 23JUL92 & immed following vax pt devel redness covering 2" x 4" w/ a 1" x 2" swelling @ the inject site; pt was treated w/a cold pack & DPH & recovered; No further details were provided;
first dose of Covid Vicine on March 8 can I still take the second dose; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (fist dose of Covid Vicine on March 8 can I still take the second dose) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (fist dose of Covid Vicine on March 8 can I still take the second dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (fist dose of Covid Vicine on March 8 can I still take the second dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Patient reported feeling pressure around her eyes and nose. She was given 50 mg of Benadryl to take orally. She continued to report these symptoms and difference in sensation of tongue and face. No visible swelling or erythema was noted. She then reported noticing some difference with swallowing at 3:39pm. Epi-pen was administered .EMS was notified. Pateint symptoms improved with adminsitration of Epi-pen. Patient was transported by EMS to local hospital for observation.
It has been one week since the injection.  I continue to have moderate/hi tinnitus.  I continue to have memory problems, thinking challenges, edgy, low grade headache, 'numbiness' of the brain, 'hollowness' of the brain.  I feel like the chemicals of my brain have been significantly impacted.   The severity of the symptoms are 99% leaning me not to have the second vaccine injection.
This spontaneous case was reported by a pharmacist and describes the occurrence of DRY MOUTH (dryness of the mouth) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DRY MOUTH (dryness of the mouth). At the time of the report, DRY MOUTH (dryness of the mouth) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication reported. No treatment medication was reported.
Patient got the 1st Shingrix in 03/25/2020, and came back today reported to us that not long after the Shingrix shot patient had chickenpox rash on her left hand. Which was very itchy and painful but gone away on its own.
Healthcare provider reports GARDASIL 9 was incorrectly administered on an unspecified date via subcutaneous route instead of intramuscular route. Caller did not provide any additional information related to the AE. No further information provided. No; No adverse event; This spontaneous report was received from a medical assistant, and refers to a male patient of unknown age. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported.  On an unknown date, the patient was vaccinated with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) for prophylaxis (strength, lot #, and expiry date were not provided). The vaccine was incorrectly administered via subcutaneous route instead of intramuscular route. No adverse events were reported.
Site: Bruising at Injection Site-Mild, Additional Details: vaccine refrigerator temperature outside the recommended range
A consumer report has been received, concerning a 2 year old female patient. The patient's concurrent diseases and concomitant medications were not reported. On an unknown date the patient received nasal FLUMIST (intranasal). The patient experienced severe vomiting, nose bleeding, severe congestion which started on 08 OCT 2013. The action taken of FLUMIST was unknown. The outcome of the events was unknown. Due to lack of customer follow-up this adverse event could not investigated by the lot information. However, trend analysis reported does not show a trend for this   complaint type. The events of vomiting and nose bleeding were considered to be non-serious by company physician. The event of congestion have been identified by the company physician from the source document and added as non-serious adverse events. Corrected report 24-SEP-2014: The reporter type of Product Complaints corrected from other to reference. Narrative was edited. Associated case ID added. PQC box was un ticked.
Information has been received from a physician concerning a 19 year old female patient who at the time of vaccination was with fever and congestion, on 02-Dec-2008 was vaccinated with 0.5ml of the "first and only dose" of GARDASIL (lot not reported) intramuscularly. There was no concomitant medication. On the same day of vaccination, 02-Dec-2008, the patient fainted, fell over, and had seizures after receiving her GARDASIL. The patient recovered at the office. She also experienced muscle soreness at the injection site, sleeplessness, and headaches after the vaccination from which she also recovered. Upon internal review seizures were considered to be other important medical event. Additional information has been requested.
This is a spontaneous report from a contactable pharmacist via a Pfizer Company representative. This pharmacist reported the same event for three patients. This is the third of three reports. An elderly female patient (65 or older) of an unspecified age and race received PREVNAR 13 at 0.5ml single dose as protection against Pneumococcal Pneumonia via unspecified route on unknown date. Medical history and concomitant medication were not reported. On unknown  date the patient experienced hard swollen arm and redness around the injection site. The outcome of the events was unknown. Sender's Comments: Linked Report(s) : US-PFIZER INC-2017081252 same reporter/drug/event, different patients; US-PFIZER INC-2017081535 same reporter/drug/event, different patients.
One week after the vaccination (1/22/2021) , I woke up because of an itchy arm and realized its the same location as my vaccine so when I looked at my arm in the mirror I saw that it was red and swollen and warm.  The redness circumference was getting bigger and bigger an because It was something that I could not find on the internet I called my dermatologist on 1/23/2021 and had a video chat and she told me to apply cortisone cream and take allergy medicines and apply cold packs and let her know if it has gone down in 2 days but it has not
breakthrough cases; breakthrough cases/ irritation in the sinuses; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 3 (booster), single, (Batch/Lot number: unknown) as dose 2, single and (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), outcome "unknown", described as "breakthrough cases"; SUSPECTED COVID-19 (medically significant), outcome "unknown", described as "breakthrough cases/ irritation in the sinuses". Patient had breakthrough just before the holidays despite being double vaccinated and boosted. Patient had just some irritation in the sinuses that lasted a couple of days. He avoided serious illness due to vaccine. Just wonderful and such a relief to know that he was adequately protected.   The lot number for bnt162b2 was not provided and will be requested during follow up.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202200073949 same reporter, drug, different patient, similar event
This spontaneous report was received from a healthcare worker refers to a patient of unknown age and gender. No concurrent condition or medical history was reported. On 19-NOV-2015, the patient was vaccinated with improperly stored dose of ROTATEQ (lot # L013192, does and route of administration not provided). No concomitant therapy was reported. No adverse effect was reported. The outcome of the event was unknown. No product quality issue was reported. This is one of the several reports from the same reporter link. Additional information has been requested.
Patient is a 76 y.o. male nursing home resident patient with history of dementia who presents today with witnessed seizure and decreased level of consciousness.  Patient was hypotensive and febrile and hypoxic on arrival.  Patient is responsive to IVF's with improved MAP of 70 with a heart rate of 84 (sinus rhythm).   His code status is DNR, but his wife (who is his MDPOA) said do not intubate, no CPR, but okay to place CVC for IVF resuscitation and possible need for pressors.  The CVC was placed via US guidance successfully with CXR confirming placement with no pneumothorax.  The CXR is consistent with bilateral lower lobe interstitial pneumonia consistent with his COVID 19 positivity.  Patient doesn't seem to have labored breathing at this time on a NRB mask which will be converted to HFNC on the floor.  His Sa)2 is 100%.     He is lethargic at this time, but woke up and took my hand away when I looked at his ears.  At baseline he can answer yes/no questions and speaks in one word sentences.  Per the ER RN, the patient is a resident at a nursing facility related to his advanced dementia.     He is being admitted for Severe Sepsis with the following sepsis criteria:  T 38.5, HR 98, BP 73/44, RR 22, NRB mask w/ SaO2 94-96%, WBC 9.38 w/ a L shift, lactic acid 3.4.  Source is lungs.  UA is negative with good urine output with foley catheter in place.     Unfortunately, he tested positive for COVID 19, but he is fully vaccinated with the 1st booster completed on 12/3/21.  He is overdue for his 2nd booster.     He will be admitted to CCU for Severe sepsis secondary to bilateral interstitial pneumonia.  Will rule out bacterial and other viral etiologies.   Asbestos related cancer to lung with mets to brain.  He had a partial lobectomy of the tumor, had surgical removal from brain as well.  He has a recurrence to the brain, after being in remission since 2016.  He had gamma knife surgery for the 2nd brain lesion.
Mild erythema @ site approx: 3 in by 5 in patch no difficulty or shortness of breath. No itching or burning or flaking no other s/s
Information has been received from a consumer concerning her cousin's currently 12 year old male child with no known allergies or medical history, who at age 2, in approximately February 1993, was vaccinated with a dose of MMR II. There were no concomitant medications. Subsequently the child developed autism. Unspecified medical attention was sought. Upon internal review, autism was determined to be an other important medical event (OMIC). The consumer also reported that the cousin's other child, who is currently 9 1/2 years old, received a dose of MMR II at age two and now has autism (WAES0302USA00291). Additional info has been requested.
knocked out due to fatigue; legs were just worked up/area where he had arthritis (knees and wrist) were affected the most/knee joints were so bad/knee joints were so bad that he could barely walk/wrist joints were also bad; This is a spontaneous report from a contactable consumer (patient) reported that an 80-year-old male patient received the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, lot number: EL1283, expiry date unknown), via an unspecified route of administration on 27Jan2021 at a single dose for COVID-19 immunization.  Medical history included ongoing arthritis which the patient had for 10 years or so and blood pressure. The patient has a positive COVID test on Sep2020. Concomitant medication included methotrexate (manufacturer unknown) for arthritis, losartan (manufacturer unknown) for blood pressure, hydroxychloroquine sulfate (PLAQUENIL) for arthritis and acetylsalicylic acid (CARTIA, reported as 'kartia') for blood pressure all ongoing and levothyroxine sodium (SYNTHROID) from an unspecified date to an unspecified date. The patient stated that he was okay the first day. Then the next day, it knocked the legs right from underneath him. His legs were just worked up and he knocked out due to fatigue. Mainly the area where he had arthritis (knees and wrist) were affected the most. He was in bed for a couple of days. At one point, his knee joints were so bad that he could barely walk. His wrist joints were also bad as he has arthritis in both knees and wrists. It lasted from the 28Jan2021 to the 30Jan2021. He has recovered from it. His knees are good, and his wrists are back to their normal aches and pains.  During the time of the report he was feeling pretty good. He was concerned about the second shot and would like more information. He wanted to know if the second shot will cause more severe side effects. The outcome of the events was recovered on 30Jan2021.
Lost 1.5 lbs, Failure to thrive, Hospitalized X 1 week
Pt developed a very large area of erythema (redness) measuring approx 14" to 16" long and approx 4 to 5" wide. Area extended from in front of armpit to below elbow on inner aspect of arm. No itching. Arm a little sore. Was seen by PMD on 10/31/03, treated with Allegra, ice to area and Tylenol.
Patient began getting dizzy within 24-48 hours after vaccine. Within 2-3 days developed persistent fevers as high as 103. Was found to have febrile neutropenia & thrombocytopenia. AKI developed, now requiring hemodialysis. Patient also required mechanical ventilation. Has been diagnosed with Hemophagocytic lymphohistiocytosis now being treated with dexamethasone & etoposide. He remains intubated.
the same day the symptoms were light but the next day i had headaches, diarrheic, nausea and was feeling very tired and had to take off for the rest of the day. I did contact the doctor a couple of doctors and they did not gave me any medicines but i just found out yesterday that i have covid.
Fever; Chills; Body aches; Vomiting; Diarrhea; This is a spontaneous report from a contactable Nurse, received via a Pfizer Sales Representative. This Nurse reported similar events for 3 patients. This is the second of 3 reports. This patient of unspecified age and gender received BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine), via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On an unspecified date, the patient experienced fever, chills, body aches, vomiting and diarrhea. The symptoms began almost immediately after receiving the vaccination and lasted for about 12 hours. The clinical outcomes of the fever, chills, body aches, vomiting and diarrhea were unknown.    The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow-up.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021072645 ;US-PFIZER INC-2021072647
Felt sick; I threw up yesterday; food poisoning; This is a spontaneous report received from a non-contactable reporter (Consumer) from medical information team.  A female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: MALAISE (non-serious) with onset 2021, outcome "unknown", described as "Felt sick"; VOMITING (non-serious) with onset 2021, outcome "unknown", described as "I threw up yesterday"; FOOD POISONING (non-serious) with onset 2021, outcome "unknown", described as "food poisoning".  Additional Information: The patient was asking if what's the longest interval between doses and if one can receive the Pfizer second dose outside of the 21 days interval. The patient also asked if she can receive the second dose if tested positive for COVID after receiving the first dose of the Pfizer COVID-19 vaccine. She heard that if someone tested positive, they can get vaccine if they let them in the building. The patient stated that she had her first shot of the Pfizer vaccine and felt sick in between. She threw up yesterday (2021). She thought that it's food poisoning. She was asking if she can get the second dose. Her doctor was not helping or proving any kind of information to her. He referred her back to Pfizer. She was scheduled to receive the second dose 18 days after dose 1.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Cough, congestion, tired.  Tested positive for COVID (home test) on 1/21/2022.
Suspected vaccination failure/vaccine gave me shingles; Had it 3 times/shingles; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   The reporter considered the vaccination failure and shingles to be related to Shingles vaccine.     Additional Information: GSK Receipt Date: 05-SEP-2022 Reporter's Comments: This case was received from consumer via interactive digital media. The reporter reported that the vaccine gave the shingles. The patient had it 3 times within 6 months at same spot. That was the last vaccine he/she would ever take. The follow-up could not be possible as no contact details were available. Additional supportive information: This case was considered as suspected vaccination failure since the details regarding the completion of primary vaccination schedule, time to onset and laboratory confirmation of shingles were unknown at the time of reporting.
pt rcvd vax; 11yo pt inadvertently rcvd dtp instead of adult td for routine booster; pt exp fever; t 101; tenderness at inject site & slight headache; rx'd w/APAP q4h following immunization through the night; next day pt still afebrile;
7cm in length and width of redness painful to palpatation. Site left thigh. Claritin 10mg 3/4cc daily, Diprolene AF cream apply thin layer 2 x a day. Amoxil 200mg 1tsp. bid
A little over 24 hours I started vomiting uncontrollably, having clear stool/foam, 102° fever for 2 days, body aches, no appetite, couldn?t stay awake, was unable to take any medication to help because I just kept throwing up.
On January 5,2021 I received first Moderna vaccine in my left arm. On January 18,2021 I noticed the injection site had become red, warm, raised with tiny welts and very itchy  The area was about 3 inches  Given steroid cream from dermotologist   I am concerned to receive second vaccine please advise
Patient got the Pfizer vaccine on 5/22 at about 4:30pm.  She did not have an immediate reaction.  The next morning she noticed some swelling in the face and it progressed to the jaw and then started to feel throat tightness at which point she went to the urgent care with an anaphylactic reaction.  They gave her a steroid injection.
Received 2nd Pfizer covid vaccine and became extremely ill and then it continued into debilitating fatigue that I still struggle with. It reactivated viruses in my body.
pt recv vax & was seen by MD because of diarrhea;@ that time a rotavirus test was positive;
This is a spontaneous report from a contactable consumer (patient). A 22-year-old (non-pregnant) female patient received BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; batch/lot# EW0170), at the age of 22, via an unspecified route of administration, on May 6, 2021, single dose, for COVID-19 immunisation. Prior to vaccination, it was unknown whether the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient received unspecified concomitant medication within two weeks prior to vaccination. The patient previously received amoxicillin on an unknown date and experienced drug allergy. Since the vaccination, patient has tested for COVID-19. On May 5, 2021, patient underwent a nasal swab test, SARS-CoV-2 test: negative. On May 6, 2021, patient experienced fever and chills for about 24 hours. Therapeutic measures taken as a result of events included Tylenol (paracetamol) from an unknown date and unknown if ongoing. The outcome of fever and chills for about 24 hours resolved on May 7, 2021. No follow-up attempts needed. No further information expected.